AMENDMENT NO. 1 TO SERIES C COMMON STOCK PURCHASE WARRANT

AMENDMENT NO. 1 TO

SERIES C COMMON STOCK PURCHASE WARRANT

This AMENDMENT NO. 1 TO SERIES C COMMON STOCK PURCHASE WARRANT (this “Amendment”) is entered into as of October 6, 2022, by and between Neptune Wellness Solutions Inc., a Quebec corporation (the “Company”), and Armistice Capital Master Fund Ltd. (the “Holder”).

WHEREAS, the Holder is the holder of a Series C Common Stock Purchase Warrant, issued as of June 23, 2022, to purchase up to 972,763 common shares of the Company, without par value (the “Original Warrant”);

WHEREAS, pursuant to Section 5(l) of the Original Warrant, the Original Warrant may be modified or amended or the provisions thereof waived with the written consent of the Company and the Holder; and

WHEREAS, the Company and the Holder desire to amend the Original Warrant as set forth in this Amendment.

NOW, THEREFORE, in consideration of the mutual agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Company and the Holder hereby agree as follows:

(Signature page follows)

 

 

NAI-▇▇▇▇▇▇▇▇▇▇v2

---

IN WITNESS WHEREOF, each of the Company and the Holder has caused this Amendment to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

COMPANY

NEPTUNE WELLNESS SOLUTIONS INC.

 

By: /s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇

Name: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇

Title: Chief Financial Officer

 

 

HOLDER

ARMISTICE CAPITAL MASTER FUND LTD.

 

By: /s/ ▇▇▇▇▇▇ ▇▇▇▇

Name: ▇▇▇▇▇▇ ▇▇▇▇

Title: CIO of Armistice Capital, LLC, the Investment Manager

 

 

2

 

NAI-▇▇▇▇▇▇▇▇▇▇v2

---